4CPS-126多发性硬化症患者使用福普定的现实世界持久性

{"title":"4CPS-126多发性硬化症患者使用福普定的现实世界持久性","authors":"N. Herranz-Muñoz, J. Sánchez-Rubio Ferrández, L. Martín-Zaragoza, M. Gómez-Bermejo, S. Solís-Cuñado, T. Molina-García","doi":"10.1136/ejhpharm-2022-eahp.394","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":393937,"journal":{"name":"Section 7: Post Congress additions","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"4CPS-126 Real-world persistence with fampridine among multiple sclerosis patients\",\"authors\":\"N. Herranz-Muñoz, J. Sánchez-Rubio Ferrández, L. Martín-Zaragoza, M. Gómez-Bermejo, S. Solís-Cuñado, T. Molina-García\",\"doi\":\"10.1136/ejhpharm-2022-eahp.394\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":393937,\"journal\":{\"name\":\"Section 7: Post Congress additions\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Section 7: Post Congress additions\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/ejhpharm-2022-eahp.394\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Section 7: Post Congress additions","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/ejhpharm-2022-eahp.394","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}